- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Oruka Therapeutics Inc (ORKA)
Oruka Therapeutics Inc stock price live, this page displays NASDAQ ORKA stock exchange data. View the ORKA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Oruka Therapeutics Inc real time stock price chart below.
What Is the Oruka Therapeutics Inc Stock Price Today?
The Oruka Therapeutics Inc stock price today is 85.500.
What Is the Stock Symbol for Oruka Therapeutics Inc?
The stock symbol for Oruka Therapeutics Inc is "ORKA."
What Stock Exchange Does Oruka Therapeutics Inc Trade On?
Oruka Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Oruka Therapeutics Inc a Good Stock to Buy?
Determining whether Oruka Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ORKA quote. (ISIN: US6876041087)
What Is the Oruka Therapeutics Inc Stock Price Today?
The Oruka Therapeutics Inc stock price today is 85.500.
What Is the Stock Symbol for Oruka Therapeutics Inc?
The stock symbol for Oruka Therapeutics Inc is "ORKA."
What Stock Exchange Does Oruka Therapeutics Inc Trade On?
Oruka Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Oruka Therapeutics Inc a Good Stock to Buy?
Determining whether Oruka Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ORKA quote. (ISIN: US6876041087)
85.500
-2.770(-3.14%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
84.600
88.270
52 wk Range
12.840
97.780
ORKA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
84.60088.270
52 wk Range
12.84097.780
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ORKA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
144.667
Upside
+69.20%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Form 144 Oruka Therapeutics For: 1 July
- Investing.com
- Form 144 Oruka Therapeutics For: 1 July
- Investing.com
- Form 13D/A ORUKA THERAPEUTICS For: 1 July
- Investing.com
- Form 4 Oruka Therapeutics Inc For: 1 July
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Analyst Ratings
13 Buy
0 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 144.667
(+69.20% Upside)
Earnings
Latest Release
May 13, 2026
EPS / Forecast
-0.48 / --
Revenue / Forecast
-- / --
Compare ORKA to Peers and Sector
Metrics to compare | ORKA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipORKAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −55.5x | −3.7x | −0.4x | |
PEG Ratio | −1.54 | 0.06 | 0.00 | |
Price/Book | 10.8x | 1.9x | 2.6x | |
Price / LTM Sales | - | 171.9x | 3.0x | |
Upside (Analyst Target) | 60.3% | 169.2% | 51.9% | |
Fair Value Upside | Unlock | −0.4% | 9.1% | Unlock |
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Oruka Therapeutics (ORKA) Stock Price Today?
The Oruka Therapeutics stock price today is 85.500 USD.
What Stock Exchange Does Oruka Therapeutics Trade On?
Oruka Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Oruka Therapeutics?
The stock symbol for Oruka Therapeutics is "ORKA."
What Is the Oruka Therapeutics Market Cap?
As of today, Oruka Therapeutics market cap is 5.150B USD.
What Is Oruka Therapeutics's Earnings Per Share (TTM)?
The Oruka Therapeutics EPS (TTM) is -1.923.
When Is the Next Oruka Therapeutics Earnings Date?
Oruka Therapeutics will release its next earnings report on Aug 17, 2026.
From a Technical Analysis Perspective, Is ORKA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Oruka Therapeutics Stock Split?
Oruka Therapeutics has split 6 times.
How Many Employees Does Oruka Therapeutics Have?
Oruka Therapeutics has 68 employees.
What is the current trading status of Oruka Therapeutics (ORKA)?
As of Jul 10, 2026, Oruka Therapeutics (ORKA) is trading at a price of 85.500 USD, with a previous close of 88.270 USD. The stock has fluctuated within a day range of 84.600 USD to 88.270 USD, while its 52-week range spans from 12.840 USD to 97.780 USD.
What Is Oruka Therapeutics (ORKA) Price Target According to Analysts?
The average 12-month price target for Oruka Therapeutics is 144.667 USD, with a high estimate of 200 USD and a low estimate of 102 USD. 13 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +69.20% Upside potential.
What Is the ORKA Premarket Price?
ORKA's last pre-market stock price is 88.300 USD. The pre-market share volume is 3,880.000, and the stock has decreased by 0.030, or 0.030%.
What Is the ORKA After Hours Price?
ORKA's last after hours stock price is 86.510 USD, the stock has decreased by -1.760, or -1.990%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.